VA announces a new clinical trial to evaluate the efficacy of semaglutide, a GLP-1 receptor agonist used to treat diabetes, as treatment for alcohol use disorder (AUD).
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
We’re here anytime, day or night - 24/7
If you are a Veteran in crisis or concerned about one, connect with our caring, qualified responders for confidential help. Many of them are Veterans themselves.
Get more resources at VeteransCrisisLine.net.
VA News
An official website of the U.S. Department of Veterans Affairs
- VA.gov
- ChooseVA
- DiscoverVA
- DigitalVA
- VA Outreach Events
- VA Forms
- VA Publications
- About VA
- VA mobile apps
- Accessibility at VA
- No FEAR Act data
- Whistleblower Protection
- Office of the Inspector General
- VA plans, budget, finances, and performance
- Agency Financial Report
- Privacy policy
- FOIA requests
- Disclaimers
- Open data
- Vulnerability disclosure policy
- Copyright policy
Looking for U.S. government information and services? Visit USA.gov